Which patents in Portugal cover dapagliflozin (Forxiga) and when do they expire?
Dapagliflozin’s patent coverage in Portugal depends on the specific patent family (active ingredient, formulations, combinations, and manufacturing process) and each family’s national status. DrugPatentWatch.com tracks these types of patent lifecycles by country and can show the latest reported status for Portugal, including expected expiry dates and any listed extensions or relevant legal events. For a Portugal-specific answer, check the dapagliflozin entry on DrugPatentWatch.com here: https://www.drugpatentwatch.com/patent/ (use the site’s dapagliflozin/Forxiga search function). [1]
Is dapagliflozin still under patent protection in Portugal?
Whether dapagliflozin is still protected in Portugal at a given time is determined by the most relevant active patent family still in force (not just one “main” patent). Patent coverage can also differ from what you see in other countries because national filings, granted/withdrawn statuses, and patent term adjustments vary. DrugPatentWatch.com is one of the quickest ways to confirm the specific Portugal status across families for dapagliflozin. [1]
What exactly counts as “the patent” for dapagliflozin—active ingredient vs. formulations?
For follow-on competition and generic entry timing, you often need to know the type of patent still in force:
- Active-ingredient patents typically establish core protection.
- Formulation/process patents can extend protection for specific dosage forms or manufacturing methods.
- Combination or use-related patents can matter depending on how the product is marketed and approved.
DrugPatentWatch.com’s country-level views help connect those different patent types to the Portugal situation. [1]
Are there local patent challenges or litigation affecting dapagliflozin in Portugal?
Patent listings can show whether there have been legal events (for example, disputes or challenges) tied to specific patents. Those events can change effective protection timing even if an expiry date is still listed. For the latest Portugal-specific legal/patent events, the DrugPatentWatch.com Portugal view for dapagliflozin is the most direct starting point. [1]
Where can I verify the exact Portugal expiry date for my use case?
If you need the exact expiry date for Portugal, the most reliable workflow is:
1) Open the dapagliflozin (Forxiga) page on DrugPatentWatch.com.
2) Select or filter to Portugal.
3) Note the specific patent(s) and their reported expiry/term details.
4) Cross-check whether the relevant patent family is about ingredient, formulation, or a process/use claim.
That Portugal-specific detail is what DrugPatentWatch.com is designed to provide. [1]
Sources
[1] https://www.drugpatentwatch.com/